Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AMG 2850 is an antagonist of transient receptor potential melastatin 8 (TRPM8).1 It inhibits menthol- or cold-induced intracellular calcium release in CHO cells expressing rat TRPM8 (IC50s = 7.3 and 150 nM, respectively). AMG 2850 is selective for TRPM8 over transient receptor potential ankyrin 1 (TRPA1), transient receptor potential vanilloid 1 (TRPV1), TRPV3, and TRPV4 (IC50s = >20, >10, >10, and >10 µM, respectively). In vivo, AMG 2850 (100 mg/kg) decreases body temperature in rats and mice. It also inhibits wet-dog shakes induced by icilin (Item No. 10137) in rats when administered at a dose of 10 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation. Mol. Pain. 8, 36 (2012).
2. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia. Naunyn Schmiedebergs Arch. Pharmacol. 388(4), 465-476 (2015).